Genmab acquires ProfoundBio in $1.8bn deal
In April 2024 Genmab and ProfoundBio entered ia definitive agreement to execute the acquisition. Credit: ArDanMe / Shutterstock.com. Genmab has concluded the previously announced acquisition
In April 2024 Genmab and ProfoundBio entered ia definitive agreement to execute the acquisition. Credit: ArDanMe / Shutterstock.com. Genmab has concluded the previously announced acquisition
The function of mast cells, which are part of the immune system, is still a mystery. Scientists at the German Cancer Research Center (DKFZ) have
During the COVID-19 pandemic, governments around the world implemented restrictive measures -; such as stay-at-home orders and school closures -; to mitigate the spread of